Identifikation und immunologische Charakterisierung von MHC ...

6. Literaturverzeichnis
apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer
Res. 58: 5315-5320.
Tanaka, C., Uzawa, K., Shibahara, T., Yokoe, H., Noma, H. and Tanzawa, H.
(2003). Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis.
J. Dent. Res. 82: 607-611.
Tanaka, K., Iwamoto, S., Gon, G., Nohara, T., Iwamoto, M. and Tanigawa, N.
(2000). Expression of survivin and its relationship to loss of apoptosis in breast
carcinomas. Clin. Cancer Res. 6: 127-134.
Thornton, AM and Shevach, EM (2000). Suppressor effector function of
CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol.
164(1): 183-190.
Toes, RE, Ossendorp, F., Offringa, R. and Melief, CJ (1999). CD4 T cells and
their role in antitumor immune responses. J. Exp. Med. 189(5): 753-756.
Tran, J., Master, Z., Yu, JL, Rak, J., Dumont, DJ and Kerbel, RS (2002). A role
for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc.
Natl. Acad. Sci. U S A 99: 4349-4354.
Trapani, JA (2005). The dual adverse effects of TGF-β secretion on tumor
progression. Canc. Cell 8(5): 349-350.
Tsukui, T., Hildesheim, A., Schiffman, MH, Lucci, J. III, Contois, D., Lawler, P.,
Rush, BB, Lorincz, AT, Corrigan, A., Burk, RD, Qu, W., Marshall, MA, Mann,
D., Carrington, M., Clerici, M., Shearer, GM, Carbone, DP, Scott, DR,
Houghten, RA and Berzofsky, JA (1996). Interleukin 2 production in vitro by
peripheral lymphocytes in response to human papillomavirus-derived
peptides: correlation with cervical pathology. Cancer Res. 56: 3967-3974.
122